2015/03/17 – Creation of a joint Inserm-Quantum Genomics laboratory at the Collège de France backed by the French National Agency for Research (ANR)

Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces the creation of a joint laboratory with the INSERM laboratory led by Catherine Llorens-Cortes at the Collège de France.

[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2015/03/QGC_CP_Labo-CARDIOBAPAI_17032015_VF_EN.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]